Press release
Impact Of Patent Expirations On The Biosimilars Market For Adalimumab, Infliximab, And Etanercept: A Significant Driver Propelling The Adalimumab, Infliximab and Etanercept Biosimilars Market In 2025
Adalimumab, Infliximab and Etanercept Biosimilars
What Is the Adalimumab, Infliximab and Etanercept Biosimilars Market Size and Projected Growth Rate?
The market size of adalimumab, infliximab, and etanercept biosimilars has seen a swift expansion in the past years. It is projected to escalate from $4.37 billion in 2024 up to $4.98 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. Factors such as increased spending on healthcare, modifications in regulation, government measures, and escalating healthcare costs have driven growth during the historic period.
The market for biosimilars of drugs like adalimumab, infliximab, and etanercept is anticipated to expand swiftly in the coming years, projected to touch $7.44 billion by 2029 with a compound annual growth rate (CAGR) of 10.5%. The escalating healthcare costs, the aging populace, and enhanced healthcare accessibility are all crucial factors propelling this growth. Throughout the forecast period, key trends would revolve around the launch of novel products, efforts towards mergers and acquisitions, establishing strategic collaborations, and boosting investment levels.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3473
What Are the Major Segments in the Adalimumab, Infliximab and Etanercept Biosimilars Market?
The adalimumab, infliximab and etanercept biosimilars market covered in this report is segmented -
1) By Product: Adalimumab Biosimilars, Infliximab Biosimilars, Cipleumab
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis, Other Applications
Subsegments:
1) By Adalimumab Biosimilars: Amjevita (Amgen), Hyrimoz (Sandoz), Cyltezo (Boehringer Ingelheim), Others
2) By Infliximab Biosimilars: Inflectra (Pfizer), Remsima (Celltrion), Ixifi (Pfizer), Others
3) By Cipleumab: Cipleumab Biosimilars, Other Biosimilars in Development
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3473&type=smp
What Are The Driving Adalimumab, Infliximab and Etanercept Biosimilars Market Evolution?
The end of patent protections for brand-name drugs has paved the way for biosimilars to penetrate the adalimumab, infliximab, and etanercept biosimilars market. For example, in the USA, the FDA gave approval to Inflectra, a drug engineered by Hospira (owned by Pfizer Inc.), designed to treat several autoimmune afflictions including rheumatoid arthritis, adult ulcerative colitis, and plaque psoriasis, following the conclusion of the patent for the branded drug Remicade. In a similar vein, the patent for Amgen's Enbrel ended in the EU, and upon this expiration, Benepali (a biosimilar to Enbrel) got the green light from the European Commission. Furthermore, after the patent for Humira expired, its biosimilars could be sold in the market. Recently, Hulio, the sixth Humira biosimilar, received FDA approval. So, the conclusion of patent protections for such branded biologic drugs like Humira, Enbrel, and Remicade is set to bolster demand in the adalimumab, infliximab, and etanercept biosimilars market.
Which Firms Dominate The Adalimumab, Infliximab and Etanercept Biosimilars Market Segments?
Major companies operating in the adalimumab, infliximab and etanercept biosimilars market include Biogen, Novartis (Sandoz), Pfizer, Amgen, Celltrion, Samsung Bioepis (Samsung Biologics), Hetero Drugs Limited, Fresenius Kabi AG, Boehringer Ingelheim, Biocon, Zydus Lifesciences Limited, Reliance Life Sciences, Torrent Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Cipla Limited, Zhejiang Hisun Pharmaceutical Co. Ltd, Bio-Thera Solutions, Ltd, Innovent Biologics (Suzhou) Co. Ltd, Janssen Biologics BV, Shanghai CP Guojian Pharmaceutical Co. Ltd, Sansheng Guojian, Shanghai Junshi Biosciences Co. Ltd, Mabwell Bioscience Co. Ltd, LG Chem, Nippon Kayaku, Mochida Pharmaceutical Co. Ltd, mAbxience, Allergan, Microgen, Geropharm, Valenta, NovaMedica Veropharm, Biocad, Roche, Bristol-Myers Squibb, Celon Pharma, SynBio, Ache, Eurofarma, Teva Pharmaceuticals, Oramed Pharmaceuticals, Entera Bio, Julphar, Hikma Pharmaceuticals, Mylan, BIOPHARMA-MEA, NeoTX, AID Genomics Limited, Altis Biologics, Next Biosciences, Viome, Inqaba Biotechnical Industries (Pty) Ltd
What Trends Are Expected to Dominate the Adalimumab, Infliximab and Etanercept Biosimilars Market in the Next 5 Years?
Leading firms in the adalimumab, infliximab, and etanercept biosimilars market are concentrating their efforts on the creation of innovative products like citrate-free adalimumab, in order to offer dependable solutions to clients. This citrate-free adalimumab is a variant of the biological drug adalimumab that excludes citrate. As an example, Fresenius Kabi, a Germany-based producer of pharmaceuticals and infusion, transfusion, and clinical nutrition technologies, secured FDA approval in December 2022 for the use of biosimilar Idacio (adalimumab) in treating chronic autoimmune disorders, fitting within all approved uses of the reference product. The product has been formulated using cutting-edge analytical techniques for application in multiple chronic ailments.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/adalimumab-infliximab-and-etanercept-biosimilar-global-market-report
Which Is The Largest Region In The Adalimumab, Infliximab and Etanercept Biosimilars Market?
North America was the largest region in the adalimumab, infliximab, and etanercept biosimilars market in 2024. The regions covered in the adalimumab, infliximab, and etanercept biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Adalimumab, Infliximab and Etanercept Biosimilars Market?
2. What is the CAGR expected in the Adalimumab, Infliximab and Etanercept Biosimilars Market?
3. What Are the Key Innovations Transforming the Adalimumab, Infliximab and Etanercept Biosimilars Industry?
4. Which Region Is Leading the Adalimumab, Infliximab and Etanercept Biosimilars Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Patent Expirations On The Biosimilars Market For Adalimumab, Infliximab, And Etanercept: A Significant Driver Propelling The Adalimumab, Infliximab and Etanercept Biosimilars Market In 2025 here
News-ID: 4002669 • Views: …
More Releases from The Business Research Company
Port and Material Handling Equipment Vehicle Market Overview, Key Growth Factors …
The port and material handling equipment vehicle sector is positioned for significant growth as advancements in technology and evolving industry demands reshape the market landscape. Increasing adoption of innovative solutions and sustainable practices are set to drive expansion, making this an exciting area to watch in the coming years. Here, we explore the market's value projections, key players, emerging trends, and the major segments shaping its future.
Projected Market Value and…
Leading Companies Spearheading Innovation and Growth in the Mining Equipment Mar …
The mining equipment sector is on track for significant expansion in the coming years, driven by evolving industry demands and technological advancements. This growth reflects a broader shift toward sustainability and efficiency within mining operations worldwide. Here's an in-depth look at the market's size, leading companies, emerging trends, and detailed segmentation.
Projected Growth and Market Size of the Mining Equipment Industry
The mining equipment market is forecasted to reach $211.25…
Future Prospects: Key Factors Influencing the Retail Vending Machine Market Unti …
The retail vending machine industry is on the path to significant expansion, driven by evolving consumer habits and technological advancements. As convenience and automation become increasingly important in retail environments, the market is set to experience rapid growth. Let's delve into the market size projections, key players, influential trends, and the segmentation landscape shaping this sector's future.
Retail Vending Machine Market Size and Growth Outlook Through 2029
The retail vending…
Analysis of Segments and Major Growth Areas in the Machinery Market
The machinery market is positioned for significant expansion over the coming years, driven by evolving technological and environmental trends. As industries embrace sustainability and digital innovations, this sector is expected to undergo transformative growth and adaptation. Let's explore the current market size projections, key players, prevailing trends, and segment-wise details shaping the machinery landscape.
Projected Growth and Market Size of the Machinery Sector by 2029
The machinery market is forecasted…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
